CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Option exercise Chief People Officer acquired 2,293 shares (option exercise)
- 4 Option exercise President and CEO acquired 91,743 shares (option exercise)
- 144 Insider Sale of Securities
- 4 Option exercise Chief Operating Officer acquired 4,587 shares (option exercise)
- 4 Planned sale President and CEO sold 25,000 shares at $4.29 ($107,168)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,714 shares (to pay taxes)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale President and CEO sold 25,000 shares at an average $4.01 ($100,192)
- 144 Insider Sale of Securities
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-3 Offering Registration Statement
- 4 Planned sale Director sold 25,000 shares at $5.02 ($125,393)
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 25,000 shares at $4.16 ($104,010)
- 144 Insider Sale of Securities
Page 2 of 35 · 689 filings